Cipher Pharmaceuticals Inc.

TSX:CPH Stock Report

Market Cap: CA$370.0m

Cipher Pharmaceuticals Management

Management criteria checks 2/4

Cipher Pharmaceuticals' CEO is Craig Mull, appointed in Jul 2019, has a tenure of 5.42 years. directly owns 3.19% of the company’s shares, worth CA$11.82M. The average tenure of the management team and the board of directors is 2.6 years and 3.6 years respectively.

Key information

Craig Mull

Chief executive officer

US$1.0m

Total compensation

CEO salary percentagen/a
CEO tenure5.4yrs
CEO ownership3.2%
Management average tenure2.6yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

We Think Cipher Pharmaceuticals (TSE:CPH) Is Taking Some Risk With Its Debt

Dec 13
We Think Cipher Pharmaceuticals (TSE:CPH) Is Taking Some Risk With Its Debt

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

CEO

Craig Mull

5.4yrs

Tenure

US$1,045,700

Compensation

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...

Leadership Team

NamePositionTenureCompensationOwnership
Craig Mull
Interim CEO & Chairman of the Board5.4yrsUS$1.05m3.19%
CA$ 11.8m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 72.3k
Emilio Presti
Director of Sales & Marketing2.9yrsno datano data
Hamed Ghanei
Chief Business Officerless than a yearno datano data

2.6yrs

Average Tenure

Experienced Management: CPH's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Craig Mull
Interim CEO & Chairman of the Board5.8yrsUS$1.05m3.19%
CA$ 11.8m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.44%
CA$ 5.3m
Douglas Deeth
Independent Director1.5yrsUS$65.57kno data
Hubert Walinski
Independent Director1.5yrsUS$62.57kno data

3.6yrs

Average Tenure

Experienced Board: CPH's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 06:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cipher Pharmaceuticals Inc. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas LoeByron Capital Markets
Prakash GowdCIBC Capital Markets
David NovakCormark Securities Inc.